Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd. has adjusted the repurchase price for its Restricted A-Shares under the 2019 Incentive Scheme, following a board meeting. They plan to repurchase and cancel 63,920 Restricted A-Shares due to performance assessments, affecting a small fraction of their total share capital. This move could influence the company’s stock dynamics and investor interest.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.